Greetings. I'd like to do a de novo assembly using Velvet 1.2.10 from reads of two different Illumina , one with 50 basepair reads and a 115bp insert, one with 250bp reads and 550bp insert. For velveth, how what insert size do I give it? An average? Pick the larger one? Thanks!
Seqanswers Leaderboard Ad
Collapse
Announcement
Collapse
No announcement yet.
X
-
you can use both.
the 2 sets of reads will be flagged as -shortPaired and -shortPaired2, respectively, when you run velveth, and the insert lengths can be
specified using the parameters -ins_length, -ins_length_sd, -ins_length2 and
-ins_length2_sd when you run velvetg.
-
From the velvet manual:
5.6 What’s long and what’s short?
Velvet was pretty much designed with micro-reads (e.g. Illumina) as short and
short to long reads (e.g. 454 and capillary) as long. Reference sequences can
also be thrown in as long.
That being said, there is no necessary distinction between the types of reads.
The only constraint is that a short read be shorter than 32kb. The real difference
is the amount of data Velvet keeps on each read. Short reads are presumably
too short to resolve many repeats, so only a minimal amount of information is
kept. On the contrary, long reads are tracked in detail through the graph.
This means that whatever you call your reads, you should be able to obtain
the same initial assembly. The differences will appear as you are trying to resolve
repeats, as long reads can be followed through the graph. On the other hand,
long reads cost more memory. It is therefore perfectly fine to store Sanger reads
as “short” if necessary.
Comment
Latest Articles
Collapse
-
by seqadmin
During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.
Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...-
Channel: Articles
09-09-2024, 10:59 AM -
-
by seqadmin
The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...-
Channel: Articles
08-27-2024, 04:44 AM -
ad_right_rmr
Collapse
News
Collapse
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by seqadmin, Today, 06:25 AM
|
0 responses
13 views
0 likes
|
Last Post
by seqadmin
Today, 06:25 AM
|
||
Started by seqadmin, Yesterday, 01:02 PM
|
0 responses
12 views
0 likes
|
Last Post
by seqadmin
Yesterday, 01:02 PM
|
||
Started by seqadmin, 09-18-2024, 06:39 AM
|
0 responses
14 views
0 likes
|
Last Post
by seqadmin
09-18-2024, 06:39 AM
|
||
Started by seqadmin, 09-11-2024, 02:44 PM
|
0 responses
14 views
0 likes
|
Last Post
by seqadmin
09-11-2024, 02:44 PM
|
Comment